Patent intelligence · US
US 9408844
Methods for treating inflammatory conditions
Methods for treating inflammatory conditions
Patent details — US 9408844
- Jurisdiction
- US
- Status
- granted
- Grant date
- Aug 9, 2016
- Expiration
- Aug 4, 2036
- Applicant
- Melior Discovery, Inc.
- Claims
- 23
- CPC classes
- A61K, A61K2800/10, A61K2800/92, A61K31/496
Quick answer
US 9408844 (Methods for treating inflammatory conditions) is held by Melior Discovery, Inc.. Status: granted. Granted Aug 9, 2016. Expires Aug 4, 2036 (10 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Melior Discovery, Inc.
- Grant date
- Expiration
- Claims
- 23
- CPC classes
- A61K, A61K2800/10, A61K2800/92, A61K31/496, A61K31/497, A61K8/494
More from Melior Discovery, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12427173
Use of bacteria, bacterial products, and other immunoregulatory entities in combination with anti-CTLA-4 and/or anti-PD-1 antibodies to treat solid tumor malignancies
granted -
US 12428415
Matriptase 2 inhibitors and uses thereof
granted -
US 12421236
Seven-membered heterocyclic derivative acting as KRAS G12C mutant protein inhibitor
granted -
US 12420085
Synergistic therapies for inter vertebral disc degeneration
granted -
US 12421231
Azaindole derivatives and their use as ERK kinase inhibitors
granted -
US 12403069
Adapter for use in a planetary mixer
granted -
US 12398179
Nanomolar peptides and derivatives to differentially modulate ephrin receptors
granted -
US 12396924
Adapter for use in a planetary mixer
granted
Frequently asked questions
What is US patent 9408844?
US 9408844 (Methods for treating inflammatory conditions) is held by Melior Discovery, Inc.. Status: granted. Granted Aug 9, 2016. Expires Aug 4, 2036 (10 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 9408844?
Melior Discovery, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 706 pharmaceutical patents for this assignee.
When does US 9408844 expire?
Our index shows an expiration date of Aug 4, 2036 (10 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.